Vaccine Contract Manufacturing Market: A Comprehensive Analysis of Industry Dynamics
The global Vaccine Contract Manufacturing Market was valued at USD 4.61 billion in 2023 and is projected to reach USD 5.16 billion in 2024 and USD 13.16 billion by 2032, growing at a CAGR of 12.4% during the forecast period 2024–2032. Demand is supported by preventive healthcare needs and ongoing development of new vaccines for emerging diseases. Prominent players include AGC Biologics,...
0 Reacties 0 aandelen 153 Views 0 voorbeeld